Literature DB >> 7162463

A recommendation for high-dose Ara-C interval treatment based on studies in a slow-growing leukemia model (BNML).

L P Colly, D W van Bekkum.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 7162463     DOI： 10.1002/mpo.2950100721

Source DB:  PubMed          Journal:  Med Pediatr Oncol        ISSN： 0098-1532


× No keyword cloud information.
  2 in total

1.  Toxicity of 1-(beta-D-arabinofuranosyl)cytosine after intravitreal injection in the rabbit eye.

Authors:  J J Diets-Ouwehand; R J de Keizer; G F Vrensen; S Groen-Jansen; J A van Best
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1992       Impact factor: 3.117

2.  Comparison of the antileukaemic activity of 5 aza-2-deoxycytidine and arabinofuranosyl-cytosine in rats with myelocytic leukaemia.

Authors:  D J Richel; L P Colly; E Lurvink; R Willemze
Journal:  Br J Cancer       Date:  1988-12       Impact factor: 7.640
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.